What's new

EMEA-001213-PIP03-23

EMEA-001213-PIP03-23

Mar 13, 2025 - 15:31
 0
EMEA-001213-PIP03-23
EMEA-001213-PIP03-23
Read More

Tags:

Previous Article

Tech Transformation: How Data Will Power Your Digital Adoption Journey

Next Article

25K hospital units show post-pandemic safety gains: 5 notes

Related Posts

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

PSUSA/00010184/202406

PSUSA/00010184/202406

Feb 13, 2025  0

Presentation - Optimizing the dosage of human prescript...

Mar 11, 2025  0